These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 5346351)

  • 21. [Comparative study of 3 measles vaccines. IV. Evaluation of effectiveness on the basis of epidemiologic observations].
    Przegl Epidemiol; 1971; 25(1):1-10. PubMed ID: 5088689
    [No Abstract]   [Full Text] [Related]  

  • 22. Studies on the combined use of killed and live measles vaccines. II. Advantages of the inhalation method.
    Okuno Y; Ueda S; Hosai H; Kitawaki T; Nakamura K; Chiang TP; Okabe S; Onaka M; Toyoshima K
    Biken J; 1965 Jun; 8(2):81-5. PubMed ID: 5837767
    [No Abstract]   [Full Text] [Related]  

  • 23. [Anti-measles vaccination with the Schwarz hyperattenuated live vaccine; post-vaccinal virological study and serological examination for 2 years].
    Boué A; Celers J
    Pathol Biol; 1967 Jan; 15(1):65-70. PubMed ID: 5340408
    [No Abstract]   [Full Text] [Related]  

  • 24. Atypical measles in children previously immunized with attenuated measles virus vaccines.
    Cherry JD; Feigin RD; Lobes LA; Shackelford PG
    Pediatrics; 1972 Nov; 50(5):712-7. PubMed ID: 5084185
    [No Abstract]   [Full Text] [Related]  

  • 25. [Evaluation of the vaccination of a mixture of inactivated and measles vaccines. 2. Investigation on occurrence of measles in Utsunomiya City].
    Tanaka H
    Nihon Shonika Gakkai Zasshi; 1972 Mar; 76(3):170-4. PubMed ID: 5065658
    [No Abstract]   [Full Text] [Related]  

  • 26. [Comparative results of anti-measles serological immunity after the disease and after vaccination].
    Topciu V; Moldovan E; Csaky N; Băcilă E
    Arch Roum Pathol Exp Microbiol; 1970 Dec; 29(4):671-5. PubMed ID: 5521121
    [No Abstract]   [Full Text] [Related]  

  • 27. [Specific anti-measles prophylaxis in Rumania. 3. Comparative study of some live attenuated virus vaccines].
    Cajal N; Cepleanu M; Cernescu C; Sorodoc Y
    Stud Cercet Inframicrobiol; 1969; 20(4):275-85. PubMed ID: 5371258
    [No Abstract]   [Full Text] [Related]  

  • 28. Development of measles vaccines in Japan.
    Ueda S
    Vaccine; 2009 May; 27(24):3230-1. PubMed ID: 19446197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Studies of specific measles prevention].
    Cajal N; Cepleanu M; Sorodoc Y; Cernescu C; Manu S; Weintraub B; Lucian M; Popescu M
    Stud Cercet Inframicrobiol; 1970; 21(3):195-211. PubMed ID: 5455840
    [No Abstract]   [Full Text] [Related]  

  • 30. Vaccination against measles: clinical trial of live measles vaccine given alone and live vaccine preceded by killed vaccine. Second report to the medical research council by the measles vaccines committee.
    Br Med J; 1968 May; 2(5603):449-52. PubMed ID: 5648287
    [No Abstract]   [Full Text] [Related]  

  • 31. [Experience with preventive measles, mumps and rubella vaccination in unified Germany].
    Gerike E; Tischer A
    Gesundheitswesen; 1993 Jan; 55(1):38-9. PubMed ID: 8435543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Unsuitability of children revaccination against measles].
    Bolotovskiĭ VM; Titova NS
    Sov Med; 1981; (9):43-8. PubMed ID: 7313794
    [No Abstract]   [Full Text] [Related]  

  • 33. Investigation and application of the USSR AMS live measles vaccine from the ESC strain for mass vacceination against measles.
    Chumakov MP; Voroshilova MK; Grachev VP; Sinyak KM; Boiko VM; Seibil VB; Rodin VI; Piven GG
    Arch Roum Pathol Exp Microbiol; 1969; 28(2):651-67. PubMed ID: 5400784
    [No Abstract]   [Full Text] [Related]  

  • 34. [Measles, mumps and rubella: vaccination rate and seroprevalence in 8th grade students of 8 different sites in Switzerland 1995/96].
    Stohrer-Draxl P; Amstad H; Grize L; Gassner M; Takken-Sahli K; Bourquin C; Braun-Fahrländer C
    Praxis (Bern 1994); 1999 Jun; 88(24):1069-77. PubMed ID: 10420798
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Administration of measles-mumps-rubella vaccination with other childhood schedule vaccines.
    Heath TC; Burgess MA; O'Brien ED
    Commun Dis Intell; 1998 Aug; 22(8):159. PubMed ID: 9735551
    [No Abstract]   [Full Text] [Related]  

  • 36. [Studies of the live AMN USSR measles vaccine from the ESC strain and its use and problems of mass vaccinations against measles].
    Czumakow MP; Woroszylowa MK; Graczew WP; Sinjak KM; Bojko WM; Sejbil WB; Rodin WI; Piwień GG
    Przegl Epidemiol; 1970; 24(2):205-11. PubMed ID: 5431794
    [No Abstract]   [Full Text] [Related]  

  • 37. Aerosol and subcutaneous measles vaccine: measles antibody responses 6 years after re-vaccination.
    Dilraj A; Sukhoo R; Cutts FT; Bennett JV
    Vaccine; 2007 May; 25(21):4170-4. PubMed ID: 17408818
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Application of live attenuated measles and mumps vaccines in children with acute leukemia.
    Torigoe S; Hirai S; Oitani K; Ito M; Ihara T; Iwasa T; Kamiya H; Sakurai M; Ueda S; Yamanishi K
    Biken J; 1981 Dec; 24(4):147-51. PubMed ID: 7346040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Measles and measles vaccine in Japan.
    Isomura S
    Nagoya J Med Sci; 1993 Mar; 55(1-4):23-32. PubMed ID: 8247103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The strategy for prevention of measles and rubella prevalence with measles-rubella (MR) vaccine in Japan.
    Ihara T
    Vaccine; 2009 May; 27(24):3234-6. PubMed ID: 19366578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.